Please use this identifier to cite or link to this item:
https://olympias.lib.uoi.gr/jspui/handle/123456789/24261| Title: | A prospective randomized phase III study in non-small-cell lung cancer comparing cisplatin, ifosfamide, vinblastine (VIP) versus cisplatin, ifosfamide and etoposide (VIP-16). Hellenic Co-Operative Oncology Group |
| Institution and School/Department of submitter: | Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής |
| Keywords: | Adult,Aged,Antineoplastic Agents/adverse effects/therapeutic use,Antineoplastic Agents, Alkylating/adverse effects/therapeutic use,Antineoplastic Agents, Phytogenic/adverse effects/therapeutic use,Antineoplastic Combined Chemotherapy Protocols/adverse effects/*therapeutic use,Carcinoma, Non-Small-Cell Lung/*drug therapy,Cisplatin/adverse effects/therapeutic use,Etoposide/adverse effects/therapeutic use,Female,Humans,Ifosfamide/adverse effects/therapeutic use,Lung Neoplasms/*drug therapy,Male,Middle Aged,Prognosis,Prospective Studies,Survival Rate,Vinblastine/adverse effects/therapeutic use |
| URI: | https://olympias.lib.uoi.gr/jspui/handle/123456789/24261 |
| ISSN: | 0923-7534 |
| Link: | http://www.ncbi.nlm.nih.gov/pubmed/8839908 |
| Appears in Collections: | Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Pavlidis-1996-a prospective randomized.pdf | 1.48 MB | Adobe PDF | View/Open Request a copy |
This item is licensed under a Creative Commons License
